These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 31589948

  • 1. High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa.
    Ghias MH, Johnston AD, Kutner AJ, Micheletti RG, Hosgood HD, Cohen SR.
    J Am Acad Dermatol; 2020 May; 82(5):1094-1101. PubMed ID: 31589948
    [Abstract] [Full Text] [Related]

  • 2. Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa.
    Oskardmay AN, Miles JA, Sayed CJ.
    J Am Acad Dermatol; 2019 Sep; 81(3):702-708. PubMed ID: 31095972
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term efficacy of infliximab in hidradenitis suppurativa.
    Paradela S, Rodríguez-Lojo R, Fernández-Torres R, Arévalo P, Fonseca E.
    J Dermatolog Treat; 2012 Aug; 23(4):278-83. PubMed ID: 22482700
    [Abstract] [Full Text] [Related]

  • 7. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa.
    Leslie KS, Tripathi SV, Nguyen TV, Pauli M, Rosenblum MD.
    J Am Acad Dermatol; 2014 Feb; 70(2):243-51. PubMed ID: 24314876
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
    Blanco R, Martínez-Taboada VM, Villa I, González-Vela MC, Fernández-Llaca H, Agudo M, González-López MA.
    Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
    [Abstract] [Full Text] [Related]

  • 10. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.
    Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, Prens EP, Schlessinger J, Zouboulis CC, van der Zee HH, Rosenfeld M, Mulani P, Gu Y, Paulson S, Okun M, Jemec GB.
    Ann Intern Med; 2012 Dec 18; 157(12):846-55. PubMed ID: 23247938
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.
    Glatt S, Jemec GBE, Forman S, Sayed C, Schmieder G, Weisman J, Rolleri R, Seegobin S, Baeten D, Ionescu L, Zouboulis CC, Shaw S.
    JAMA Dermatol; 2021 Nov 01; 157(11):1279-1288. PubMed ID: 34406364
    [Abstract] [Full Text] [Related]

  • 12. Infliximab for hidradenitis suppurativa.
    Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS.
    Br J Dermatol; 2003 Nov 01; 149(5):1046-9. PubMed ID: 14632813
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
    Özer İ, Karaçin C, Adışen E, Güz G, Ali Gürer M.
    Dermatol Ther; 2017 Mar 01; 30(2):. PubMed ID: 27862787
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR, Bos JD.
    Br J Dermatol; 2008 Feb 01; 158(2):370-4. PubMed ID: 18047504
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy.
    Shanmugam VK, Mulani S, McNish S, Harris S, Buescher T, Amdur R.
    Int J Dermatol; 2018 Jan 01; 57(1):62-69. PubMed ID: 29130482
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.